These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29973593)

  • 1. miR-130a and miR-145 reprogram Gr-1
    Ishii H; Vodnala SK; Achyut BR; So JY; Hollander MC; Greten TF; Lal A; Yang L
    Nat Commun; 2018 Jul; 9(1):2611. PubMed ID: 29973593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.
    Li Z; Pang Y; Gara SK; Achyut BR; Heger C; Goldsmith PK; Lonning S; Yang L
    Int J Cancer; 2012 Dec; 131(11):2584-95. PubMed ID: 22487809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulating the expression of IFN regulatory factor 8 alters the protumorigenic behavior of CD11b+Gr-1+ myeloid cells.
    Stewart TJ; Liewehr DJ; Steinberg SM; Greeneltch KM; Abrams SI
    J Immunol; 2009 Jul; 183(1):117-28. PubMed ID: 19542426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.
    Yan HH; Pickup M; Pang Y; Gorska AE; Li Z; Chytil A; Geng Y; Gray JW; Moses HL; Yang L
    Cancer Res; 2010 Aug; 70(15):6139-49. PubMed ID: 20631080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
    Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
    Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
    Yang L; Huang J; Ren X; Gorska AE; Chytil A; Aakre M; Carbone DP; Matrisian LM; Richmond A; Lin PC; Moses HL
    Cancer Cell; 2008 Jan; 13(1):23-35. PubMed ID: 18167337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective chemoimmunotherapy with anti-TGFβ antibody and cyclophosphamide in a mouse model of breast cancer.
    Chen X; Yang Y; Zhou Q; Weiss JM; Howard OZ; McPherson JM; Wakefield LM; Oppenheim JJ
    PLoS One; 2014; 9(1):e85398. PubMed ID: 24416401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity.
    Suzuki E; Kapoor V; Jassar AS; Kaiser LR; Albelda SM
    Clin Cancer Res; 2005 Sep; 11(18):6713-21. PubMed ID: 16166452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premetastatic soil and prevention of breast cancer brain metastasis.
    Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
    Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions.
    Shaw AK; Pickup MW; Chytil A; Aakre M; Owens P; Moses HL; Novitskiy SV
    PLoS One; 2015; 10(1):e0117908. PubMed ID: 25629162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-γ regulates survival and function of tumor-induced CD11b+ Gr-1high myeloid derived suppressor cells by modulating the anti-apoptotic molecule Bcl2a1.
    Medina-Echeverz J; Haile LA; Zhao F; Gamrekelashvili J; Ma C; Métais JY; Dunbar CE; Kapoor V; Manns MP; Korangy F; Greten TF
    Eur J Immunol; 2014 Aug; 44(8):2457-67. PubMed ID: 24810636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.
    Ostrand-Rosenberg S; Clements VK; Terabe M; Park JM; Berzofsky JA; Dissanayake SK
    J Immunol; 2002 Nov; 169(10):5796-804. PubMed ID: 12421960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Zhao L; Huang S; Mei S; Yang Z; Xu L; Zhou N; Yang Q; Shen Q; Wang W; Le X; Lau WB; Lau B; Wang X; Yi T; Zhao X; Wei Y; Warner M; Gustafsson JÅ; Zhou S
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3673-E3681. PubMed ID: 29592953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
    Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
    Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Promoting Effects of Myeloid-Derived Suppressor Cells Are Potentiated by Hypoxia-Induced Expression of miR-210.
    Noman MZ; Janji B; Hu S; Wu JC; Martelli F; Bronte V; Chouaib S
    Cancer Res; 2015 Sep; 75(18):3771-87. PubMed ID: 26206559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-conditioned Gr-1(+)CD11b(+) myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro.
    Han EC; Lee J; Ryu SW; Choi C
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1218-25. PubMed ID: 24388986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastases.
    Chow MT; Sceneay J; Paget C; Wong CS; Duret H; Tschopp J; Möller A; Smyth MJ
    Cancer Res; 2012 Nov; 72(22):5721-32. PubMed ID: 22986739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.
    Bayne LJ; Beatty GL; Jhala N; Clark CE; Rhim AD; Stanger BZ; Vonderheide RH
    Cancer Cell; 2012 Jun; 21(6):822-35. PubMed ID: 22698406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.